Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Buy
71
OCGN Quote, Financials, Valuation and Earnings
Last price:
$1.70
Seasonality move
:
19.96%
Day range:
$1.63 - $1.84
52-week range:
$0.52 - $1.96
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
92.76x
P/B ratio:
149.43x
Volume:
8.2M
Avg. volume:
5.1M
1-year change:
136.36%
Market cap:
$527.8M
Revenue:
$4.1M
EPS (TTM):
-$0.22
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $43K | -- | $2.5M | $6M | $4.1M | |
| Revenue Growth (YoY) | -- | -100% | -- | 142.61% | -32.82% | |
| Cost of Revenues | -- | $589K | $480K | $704K | $2M | |
| Gross Profit | -- | -$589K | $2M | $5.3M | $2.1M | |
| Gross Profit Margin | -- | -- | 80.71% | 88.34% | 51.47% | |
| R&D Expenses | $6.4M | $35.1M | $55.7M | $38.9M | $30.2M | |
| Selling, General & Admin | $8M | $22.9M | $35.4M | $32M | $26.7M | |
| Other Inc / (Exp) | -$6.8M | -$389K | $2.3M | $2.5M | $703K | |
| Operating Expenses | $14.3M | $57.4M | $91.1M | $70.9M | $56.8M | |
| Operating Income | -$14.3M | -$58M | -$89.1M | -$65.5M | -$54.8M | |
| Net Interest Expenses | $721K | $79K | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$21.8M | -$58.4M | -$86.8M | -$63.1M | -$54.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -$52K | -- | -- | -- | |
| Net Income to Company | -$21.8M | -$58.4M | -$86.8M | -$63.1M | -$54.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$21.8M | -$58.4M | -$86.8M | -$63.1M | -$54.1M | |
| Basic EPS (Cont. Ops) | -$0.31 | -$0.30 | -$0.40 | -$0.26 | -$0.20 | |
| Diluted EPS (Cont. Ops) | -$0.31 | -$0.30 | -$0.40 | -$0.26 | -$0.20 | |
| Weighted Average Basic Share | $112.2M | $195M | $214.6M | $244.3M | $271M | |
| Weighted Average Diluted Share | $112.2M | $195M | $214.6M | $244.3M | $271M | |
| EBITDA | -$21M | -$57.4M | -$88.6M | -$64.8M | -$52.8M | |
| EBIT | -$21.1M | -$58M | -$89.1M | -$65.5M | -$54.8M | |
| Revenue (Reported) | $43K | -- | $2.5M | $6M | $4.1M | |
| Operating Income (Reported) | -$14.3M | -$58M | -$89.1M | -$65.5M | -$54.8M | |
| Operating Income (Adjusted) | -$21.1M | -$58M | -$89.1M | -$65.5M | -$54.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $3.7M | $1.1M | $1.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -69.29% | 54.23% | |
| Cost of Revenues | $124K | $270K | $177K | $613K | $950K | |
| Gross Profit | -$124K | -$270K | $3.5M | $523K | $802K | |
| Gross Profit Margin | -- | -- | 95.22% | 46.04% | 45.78% | |
| R&D Expenses | $6.3M | $15.6M | $7M | $8.1M | $10.2M | |
| Selling, General & Admin | $4.5M | $7.5M | $9.1M | $6.3M | $8.2M | |
| Other Inc / (Exp) | -$18K | $1.2M | $714K | $282K | -- | |
| Operating Expenses | $10.7M | $22.8M | $16M | $13.8M | $18.4M | |
| Operating Income | -$10.8M | -$23.1M | -$12.4M | -$13.3M | -$17.6M | |
| Net Interest Expenses | $19K | -- | -- | -- | $1.3M | |
| EBT. Incl. Unusual Items | -$10.8M | -$21.9M | -$11.7M | -$13M | -$20.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$52K | -- | -- | -- | -- | |
| Net Income to Company | -$10.8M | -$140.7M | -$11.7M | -$13M | -$20.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$10.8M | -$21.9M | -$11.7M | -$13M | -$20.1M | |
| Basic EPS (Cont. Ops) | -$0.05 | -$0.10 | -$0.05 | -$0.05 | -$0.07 | |
| Diluted EPS (Cont. Ops) | -$0.05 | -$0.10 | -$0.05 | -$0.05 | -$0.07 | |
| Weighted Average Basic Share | $198.8M | $216.6M | $256.5M | $278.2M | $304M | |
| Weighted Average Diluted Share | $198.8M | $216.6M | $256.5M | $278.2M | $304M | |
| EBITDA | -$10.7M | -$22.8M | -$12.3M | -$12.6M | -$16.7M | |
| EBIT | -$10.8M | -$23.1M | -$12.4M | -$13.3M | -$17.6M | |
| Revenue (Reported) | -- | -- | $3.7M | $1.1M | $1.8M | |
| Operating Income (Reported) | -$10.8M | -$23.1M | -$12.4M | -$13.3M | -$17.6M | |
| Operating Income (Adjusted) | -$10.8M | -$23.1M | -$12.4M | -$13.3M | -$17.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $5.5M | $4.7M | $5.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $327.5K | $1M | $698K | $1.5M | $3.4M | |
| Gross Profit | -$327.5K | -$1M | $4.8M | $3.2M | $2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $29.6M | $39.6M | $48.8M | $30.9M | $35.5M | |
| Selling, General & Admin | $17.7M | $35.6M | $33.8M | $25.5M | $27.8M | |
| Other Inc / (Exp) | -$196K | $1.3M | $2.9M | $823K | -- | |
| Operating Expenses | $46.9M | $74.3M | $82.2M | $55.6M | $61.7M | |
| Operating Income | -$47.2M | -$75.3M | -$77.4M | -$52.4M | -$59.8M | |
| Net Interest Expenses | $225.2K | $20K | -- | -- | $3.3M | |
| EBT. Incl. Unusual Items | -$47.6M | -$74M | -$74.5M | -$51.1M | -$64M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$52K | -- | -- | -- | -- | |
| Net Income to Company | -$47.6M | -$192.8M | $39.3M | -$51.1M | -$64M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$47.6M | -$74M | -$74.5M | -$51.1M | -$64M | |
| Basic EPS (Cont. Ops) | -$0.25 | -$0.35 | -$0.32 | -$0.20 | -$0.22 | |
| Diluted EPS (Cont. Ops) | -$0.22 | -$0.35 | -$0.32 | -$0.20 | -$0.22 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$46.9M | -$74.3M | -$76.7M | -$50.9M | -$56.4M | |
| EBIT | -$47.2M | -$75.3M | -$77.4M | -$52.4M | -$59.8M | |
| Revenue (Reported) | -- | -- | $5.5M | $4.7M | $5.4M | |
| Operating Income (Reported) | -$47.2M | -$75.3M | -$77.4M | -$52.4M | -$59.8M | |
| Operating Income (Adjusted) | -$47.2M | -$75.3M | -$77.4M | -$52.4M | -$59.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $4.6M | $3.3M | $4.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $124K | $770K | $525K | $1.4M | $2.8M | |
| Gross Profit | -$124K | -$770K | $4.1M | $1.9M | $1.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $28M | $32.5M | $31.8M | $23.3M | $27.2M | |
| Selling, General & Admin | $15.5M | $28.2M | $26.8M | $20.4M | $21.4M | |
| Other Inc / (Exp) | -$380K | $1.3M | $1.9M | $268K | $179K | |
| Operating Expenses | $43.3M | $59.9M | $58.1M | $42.8M | $47.7M | |
| Operating Income | -$43.5M | -$60.7M | -$54M | -$40.9M | -$45.9M | |
| Net Interest Expenses | $19K | -- | -- | -- | $3.3M | |
| EBT. Incl. Unusual Items | -$43.8M | -$59.4M | -$52.1M | -$40.2M | -$50.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$52K | -- | -- | -- | -- | |
| Net Income to Company | -$43.8M | -$178.2M | -$52.1M | -$40.2M | -$50.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$43.8M | -$59.4M | -$52.1M | -$40.2M | -$50.1M | |
| Basic EPS (Cont. Ops) | -$0.22 | -$0.28 | -$0.22 | -$0.15 | -$0.17 | |
| Diluted EPS (Cont. Ops) | -$0.22 | -$0.28 | -$0.22 | -$0.15 | -$0.17 | |
| Weighted Average Basic Share | $580.7M | $638.1M | $720.3M | $792.8M | $888.1M | |
| Weighted Average Diluted Share | $580.7M | $638.1M | $720.3M | $792.8M | $888.1M | |
| EBITDA | -$43.2M | -$59.9M | -$53.5M | -$39.5M | -$43.1M | |
| EBIT | -$43.5M | -$60.7M | -$54M | -$40.9M | -$45.9M | |
| Revenue (Reported) | -- | -- | $4.6M | $3.3M | $4.6M | |
| Operating Income (Reported) | -$43.5M | -$60.7M | -$54M | -$40.9M | -$45.9M | |
| Operating Income (Adjusted) | -$43.5M | -$60.7M | -$54M | -$40.9M | -$45.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $24M | $95M | $90.9M | $39.5M | $58.5M | |
| Short Term Investments | -- | -- | $13.4M | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $1.8M | -- | -- | -- | -- | |
| Other Current Assets | -- | $7.7M | $7.6M | $3.5M | $3.2M | |
| Total Current Assets | $25.9M | $102.6M | $98.5M | $43M | $61.7M | |
| Property Plant And Equipment | $633K | $2.8M | $6.1M | $17.3M | $16.6M | |
| Long-Term Investments | -- | $151K | -- | -- | $307K | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $865K | $2M | $4.1M | $4.3M | $4.2M | |
| Total Assets | $27.4M | $105.8M | $109.6M | $65.5M | $83.3M | |
| Accounts Payable | $395K | $2.3M | $8.1M | $3.2M | $4.2M | |
| Accrued Expenses | $1.3M | $2.6M | $5.6M | $876K | $1.9M | |
| Current Portion Of Long-Term Debt | $234K | -- | -- | -- | $1.3M | |
| Current Portion Of Capital Lease Obligations | $44K | $363K | $498K | $574K | $519K | |
| Other Current Liabilities | -- | -- | $357K | $151K | $2.8M | |
| Total Current Liabilities | $3.6M | $7M | $28.5M | $17.1M | $21.6M | |
| Long-Term Debt | $1.8M | $2.9M | $5.9M | $6.4M | $30.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.8M | $9.9M | $35.6M | $24.9M | $53.7M | |
| Common Stock | $1.8M | $2M | $2.2M | $2.6M | $2.9M | |
| Other Common Equity Adj | -- | -- | $26K | $20K | $48K | |
| Common Equity | $21.6M | $95.8M | $74M | $40.6M | $29.6M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $21.6M | $95.8M | $74M | $40.6M | $29.6M | |
| Total Liabilities and Equity | $27.4M | $105.8M | $109.6M | $65.5M | $83.3M | |
| Cash and Short Terms | $24M | $95M | $90.9M | $39.5M | $58.5M | |
| Total Debt | $2.1M | $2.9M | $5.9M | $6.4M | $32M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $107.3M | $101.6M | $53.5M | $38.7M | $32.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $6.1M | $5.9M | -- | -- | -- | |
| Other Current Assets | -- | -- | $3.1M | $2M | -- | |
| Total Current Assets | $113.5M | $107.5M | $56.6M | $40.7M | $37.6M | |
| Property Plant And Equipment | $2.5M | $4.5M | $14.5M | $17.1M | $14.9M | |
| Long-Term Investments | $151K | -- | -- | $305K | $314K | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $1.8M | $4.2M | $3.7M | $4.1M | -- | |
| Total Assets | $116.3M | $116.2M | $74.7M | $61.9M | $57.6M | |
| Accounts Payable | $2.1M | $6.5M | $2.9M | $1.5M | $4.6M | |
| Accrued Expenses | $2.7M | $5.6M | $2M | $1.8M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $1.3M | $1.3M | -- | |
| Current Portion Of Capital Lease Obligations | $172K | $443K | $540K | $477K | -- | |
| Other Current Liabilities | -- | -- | $1.5M | $545K | -- | |
| Total Current Liabilities | $6.2M | $14.9M | $11.1M | $15.8M | $20.4M | |
| Long-Term Debt | $3M | $6M | $4.7M | $5M | $32.1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $9.2M | $20.9M | $16.3M | $21.3M | $54.1M | |
| Common Stock | $2M | $2.2M | $2.6M | $2.9M | $3.1M | |
| Other Common Equity Adj | -- | $30K | $27K | $23K | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $107.1M | $95.3M | $58.4M | $40.6M | $3.5M | |
| Total Liabilities and Equity | $116.3M | $116.2M | $74.7M | $61.9M | $57.6M | |
| Cash and Short Terms | $107.3M | $101.6M | $53.5M | $38.7M | $32.6M | |
| Total Debt | $3.1M | $6M | $5.9M | $6.3M | $32.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$21.8M | -$58.4M | -$86.8M | -$63.1M | -$54.1M | |
| Depreciation & Amoritzation | $102K | $589K | $480K | $704K | $2M | |
| Stock-Based Compensation | $660K | $7M | $10.5M | $9.2M | $7.4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$14.7M | -$47.9M | -$60.1M | -$62.1M | -$42.1M | |
| Capital Expenditures | $307K | $939K | $4.5M | $10.5M | $3.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$307K | -$1.8M | -$17M | $3.1M | -$3.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $921K | -- | $500K | $500K | $30M | |
| Long-Term Debt Repaid | -$5.6M | -$10K | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.5M | -$8.5M | -$592K | -$423K | -$3.7M | |
| Cash From Financing | $31.6M | $120.7M | $59.5M | $20.9M | $64.9M | |
| Beginning Cash (CF) | $7.6M | $95M | $77.6M | $39.5M | $58.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $16.6M | $70.9M | -$17.5M | -$38.1M | $19.4M | |
| Ending Cash (CF) | $24.2M | $165.9M | $60M | $1.4M | $77.9M | |
| Levered Free Cash Flow | -$15M | -$48.9M | -$64.5M | -$72.5M | -$45.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$10.8M | -$140.7M | -$11.7M | -$13M | -$20.1M | |
| Depreciation & Amoritzation | $124K | $270K | $177K | $613K | $950K | |
| Stock-Based Compensation | $1.3M | $2.5M | $2.2M | $1.9M | $2M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$8.1M | -$14.3M | -$13.7M | -$11.3M | -$12.9M | |
| Capital Expenditures | $350K | $844K | $3.4M | $507K | $91K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$350K | -$83K | -$3.4M | -$507K | -$86K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $500K | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -$100K | -$184K | |
| Other Financing Activities | -- | -$141K | -$20.8M | -$2.8M | -- | |
| Cash From Financing | $110K | $962K | -$35K | $34.8M | $18.5M | |
| Beginning Cash (CF) | $107.3M | $101.6M | $53.5M | $38.7M | $32.6M | |
| Foreign Exchange Rate Adjustment | -- | $20K | $5K | -$5K | $46K | |
| Additions / Reductions | -$8.3M | -$13.4M | -$17.1M | $23M | $5.6M | |
| Ending Cash (CF) | $99.1M | $88.2M | $36.4M | $61.7M | $38.2M | |
| Levered Free Cash Flow | -$8.4M | -$15.1M | -$17.1M | -$11.8M | -$13M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$47.6M | -$192.8M | $39.3M | -$51.1M | -$64M | |
| Depreciation & Amoritzation | $395.5K | $1M | $235K | $1.5M | $3.4M | |
| Stock-Based Compensation | $4.4M | $10.6M | $10.2M | $7.3M | $7.6M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$39.4M | -$56M | -$67.7M | -$43.1M | -$53.4M | |
| Capital Expenditures | $1.1M | $2.5M | $9.8M | $6.1M | $163K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.9M | -$1.9M | -$9.5M | -$6.1M | -$289K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.3M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$8.9M | -$341K | -$674K | -$2.9M | -- | |
| Cash From Financing | $129.5M | $51.9M | $29M | $34.7M | $47.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $88.2M | -$5.9M | -$48.1M | -$14.5M | -$6.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$40.5M | -$58.5M | -$77.4M | -$49.2M | -$53.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$43.8M | -$178.2M | -$52.1M | -$40.2M | -$50.1M | |
| Depreciation & Amoritzation | $217K | $770K | $525K | $1.4M | $2.8M | |
| Stock-Based Compensation | $4.3M | $7.9M | $7.5M | $5.6M | $5.7M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$35.1M | -$43.2M | -$50.8M | -$31.8M | -$43M | |
| Capital Expenditures | $874K | $2.4M | $7.8M | $3.4M | $150K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.6M | -$1.7M | $5.8M | -$3.4M | -$276K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $500K | $500K | -- | -- | |
| Long-Term Debt Repaid | -$10K | -- | -- | -- | -$1M | |
| Repurchase of Common Stock | -- | -- | -- | -$0 | -- | |
| Other Financing Activities | -$8.5M | -$341K | -$423K | -$2.9M | -$184K | |
| Cash From Financing | $120.1M | $51.3M | $20.9M | $34.7M | $17.3M | |
| Beginning Cash (CF) | $176.5M | $346.4M | $192.3M | $80.8M | $97.4M | |
| Foreign Exchange Rate Adjustment | -- | $20K | $2K | $3K | $10K | |
| Additions / Reductions | $83.3M | $6.5M | -$24.1M | -$461K | -$25.9M | |
| Ending Cash (CF) | $259.8M | $352.9M | $168.2M | $80.3M | $71.4M | |
| Levered Free Cash Flow | -$36M | -$45.6M | -$58.5M | -$35.2M | -$43.2M | |
Related Companies
Get OCGN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
OCGN
Sector
P/E ratio
--
23.89x
PEG ratio
-0.70x
-0.01x
P/B ratio
149.43x
1.81x
Price / LTM sales
92.76x
1.59x
Growth Metrics
OCGN
Sector
Revenue growth
54.23%
4.35%
Earnings growth
-41.63%
9.8%
Revenue (5-year growth)
--
6.41%
Earnings forecast
-$0.06
-$0.18
Profitability
OCGN
Sector
Profitability FY 2024
$2.1M
$3.2M
Return on invested capital
-139.38%
-32.76%
Return on assets
-99.74%
-29.32%
Return on equity
-345.08%
-38.6%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Mar
5
Estimated Next Earnings Date
Feb
4
Balance Sheet
OCGN
Sector
Total cash
$32.6M
$25.4M
Short term investments
--
$25.1M
Total assets
$83.3M
$74.7M
Long term debt
$32.1M
$3.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
